Greater Cannabis Company (GCAN) Share-based Compensation Growth (1y) (2018)

Greater Cannabis Company (GCAN) Share-based Compensation Growth (1y) (2018) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.47%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 47.06%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 8.79%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 281.05%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 92.83%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 5.49%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 61.54%
10 Greater Cannabis Company 292,929.85 292,929.85 - -

Historic Data

Download Data
DateValue
Mar 31, 2018 -99.52%